NORGES BANK

Bank

Position in ROIV — Roivant Sciences Ltd.

CIK 1374170 OSLO, Q8

Position in ROIV

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$168,013,034

+$55,262,894 QoQ

Shares Held

4,747,472

-8.6% QoQ

Ownership

0.657%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#25

of 494 holders

Holding Since

Jun 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. ROIV ranks #10 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,971,681	$1,476,123,103
2	REGN	Regeneron Pharmaceuticals, Inc.	1,172,808	$731,292,700
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,271,813	$683,883,867
4	BMRN	Biomarin Pharmaceutical Inc	8,207,954	$469,659,127
5	RVMD	Revolution Medicines, Inc.	2,157,479	$404,052,667
6	INSM	INSMED Inc	3,377,641	$360,124,083
7	ARWR	Arrowhead Pharmaceuticals, Inc.	3,896,536	$317,606,649
8	RPRX	Royalty Pharma plc	5,336,084	$299,194,229

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$168,013,034	4,747,472	-8.6%	Shares	Sole	2026-08-12
2025-12-31	$112,750,140	5,195,859	+742.3%	Shares	Sole	2026-02-10
2025-06-30	$6,952,113	616,869	-86.5%	Shares	Sole	2025-08-13
2025-03-31	$46,230,563	4,581,820	+3.4%	Shares	Sole	2026-05-11
2024-12-31	$52,442,555	4,433,014	+1.1%	Shares	Sole	2025-02-12
2024-09-30	$50,613,747	4,385,940	+3.4%	Shares	Sole	2025-11-12
2024-06-30	$44,825,012	4,240,777	-0.6%	Shares	Sole	2024-08-14
2024-03-31	$44,970,933	4,266,692	+15.4%	Shares	Sole	2025-05-14
2023-12-31	$41,505,709	3,695,967	+46.7%	Shares	Sole	2024-02-09
2023-09-30	$29,434,265	2,520,057	+2213.4%	Shares	Sole	2024-11-13
2023-06-30	$1,098,034	108,932	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.